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Little is known about how reproductive factors affect the risk of breast cancers of different histology. In an analysis of prospective data
on 1.2 million middle-aged UK women, we used proportional hazards models to estimate the relative risks of six histological types in
relation to menarche, childbearing and menopause. During 8.7 million person-years of follow-up, 17923 ductal, 3332 lobular, 1062
tubular, 944 mixed ductal lobular, 330 mucinous and 117 medullary cancers were diagnosed. The effect of both age at menarche and
age at first birth was greatest for lobular tumours; relative risks per 5-year increase in age at menarche for ductal, lobular, and tubular
cancers were 0.93 (0.87–0.99), 0.65 (0.56–0.76), and 0.75 (0.57–0.98), respectively (P-value for heterogeneity¼0.0001); and the
relative risks per 5-year increase in age at first birth were 1.10 (1.07–1.12), 1.23 (1.17–1.29), and 1.13 (1.03–1.23), respectively (P-
value for heterogeneity¼0.0006). Increasing parity reduced the risk of each tumour type, except medullary cancers, but the
reduction in risk was greater for mucinous cancers than for any other subtype considered (Po0.05 for comparison with each other
subtype in turn). The effect of menopause did not vary significantly by tumour histology. Meta-analysis of published results on the
effects of age at menarche and age at first birth on ductal and lobular cancers were in keeping with our findings.
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Despite the fact that reproductive factors are among the most
established risk factors for breast cancer, little is known about
whether their effects differ by tumour histology. Few studies of
breast cancer in relation to reproductive factors have had sufficient
power to estimate reliably the risk of specific subtypes according to
detailed reproductive history. We report here on the relationship
between age at menarche, parity, age at first birth and age at
menopause, and the risk of six histological subtypes of breast
cancer in a large prospective study of women in the UK, and
present meta-analyses of published results.
MATERIALS AND METHODS
The Million Women Study recruited 1.3 million middle-aged
women in 1996–2001, who completed a questionnaire about
reproductive factors, sociodemographic factors and other personal
characteristics. They were resurveyed about 3 years after recruit-
ment to update information on menopausal status and other
factors, with a 65% response rate. Full details of the study design
and methods are described elsewhere (The Million Women Study
Collaborative Group, 1999) and questionnaires can be viewed at
http://www.millionwomenstudy.org. All participants were flagged
on the National Health Service (NHS) Central Registers so that
cancer registrations and deaths are routinely notified to the study
investigators. These registers provide information on the date of
each such event and the cancer site and morphology codes using
the 10th revision of the International Classification of Diseases
(ICD10) (World Health Organisation, 1992). All participants gave
their written consent and ethical approval was granted by the
Oxford and Anglia Multi-Centre Research Ethics Committee.
The relationship between the risk of incident invasive breast
cancer and various reproductive factors was examined separately for
six histological subtypes: ductal (ICD10-O code 8500/3), lobular
(ICD10-O code 8520/3), mixed ductal lobular (ICD10-O code 8522/3),
tubular (ICD10-O code 8211/3) medullary (ICD10-O code 8510/3),
and mucinous (ICD10-O code 8480/3). The variables for these
analyses were derived from the information provided at baseline,
except for those related to menopause, and to hormone-replacement
therapy (HRT) use, which were updated from the resurvey, wherever
possible. At each point of contact, a woman’s menopausal status and
HRT use was defined according to the criteria outlined previously
(Million Women Study Collaborators, 2003). For all women who
reported being pre- or perimenopausal at last contact, menopausal
status was treated as unknown beyond 4 years after last contact.
Because HRT use is known to be strongly related to age at
menopause, analyses of menopausal status and age at menopause
were restricted to never-users of HRT. Women diagnosed with any
invasive cancer other than non-melanoma skin cancer (ICD10 C44)
before recruitment were excluded from all analyses. For the
remaining women, person-years were contributed from the date of
recruitment until the date of registration for a breast cancer of
interest, the date of death, or the end of follow-up, which was defined
as 31 December 2006 for all regions, except for the Thames and West
Midlands (30 June 2006), North and Yorkshire and Mersey (31
December 2005) and Scotland (31 December 1999). Women
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ydiagnosed with any non-breast (or non-melanoma skin) cancer
during follow-up were censored at the diagnosis date.
Proportional hazards models were used to estimate the relative
risk (RR) of developing specific histological types of breast cancer
according to age at menarche, parity, age at first birth, menopausal
status, and age at menopause with attained age as the underlying
time variable. All analyses were routinely stratified by broad
geographical region (10 regions corresponding to the 10 areas
covered by the cancer registries providing data), and adjusted for
quintiles of socioeconomic group based on deprivation index
(Townsend et al, 1988), use of HRT (never, past, current use of
duration: o5 years, 5–9 years, 10þ years), body mass index in
kg/m
2 (o25, 25–29, 30þ), family history of breast cancer (no,
yes), average alcohol consumption (0, 1–2, 3–6, 7–14, 15þ
drinks/week), and where appropriate, for age at menarche (o12,
12–13, 14þ), parity (0, 1, 2, 3, 4þ), age at first birth (nulliparous,
o20, 20–24, 25–29, 30þ) and time since menopause (premeno-
pausal, perimenopausal, postmenopausal with time since meno-
pause: o5, 5–9, 10þ years). Time since menopause and HRT use
were treated as categorical time-dependent variables. Women with
missing values for a given adjustment variable were assigned to a
separate category for that variable. To assess the effect of including
women with missing information for some adjustment factors,
analyses were repeated for those with known values for all
adjustment variables.
Where analyses involve risk comparison across more than two
categories, variances were estimated by treating the RRs as floating
absolute risks (Easton et al, 1991) and results are, therefore, presented
in the form of relative risks and their corresponding floated
confidence intervals. Results in the text, which refer to a specific
comparison of two categories, or to an estimate of trend, are
presented in the form of conventional RRs and their corresponding
confidence intervals. All analyses were performed using the statistical
package Stata, version 9.2 (StataCorp, 2007). Formal tests of
heterogeneity in the relationship between various reproductive
factors and breast cancer risk by histological type were carried out
using a competing risks approach. Although results are presented for
all six subtypes of breast cancer considered, tests of heterogeneity
were sometimes restricted to ductal, lobular and tubular cancers as
mixed ductal lobular cancers cannot be assumed to be distinct from
ductal or lobular tumours, and the numbers of medullary and
mucinous cancers were usually too few to allow reliable comparisons
with the other subtypes.
We also conducted a meta-analysis of published data for ductal
and lobular cancers based on relevant studies identified by 31
August 2008 through searches of PUBMED, and supplemented by
searches of reference lists in identified papers. Summary relative
risks were estimated by calculating the weighted average of the
study-specific log RRs, with weights proportional to the inverse of
the variances of the study-specific log relative risks. Studies were
grouped according to study design, and summary estimates were
calculated separately for case–control and cohort studies.
RESULTS
A total of 1193604 women, aged 50–64 years, without previous
cancer (except non-melanoma skin cancer) were followed up for
incident breast cancer over 8.7 million person-years. During this
period, 27397 were registered with breast cancer with a median age
at diagnosis of 60 years (inter-quartile range: 56–64). The three
commonest tumour types were ductal (65% of the total), lobular
Table 1 Relative risk
a of specific histological types of breast cancer according to reproductive history
Ductal Lobular Tubular Mixed ductal lobular Mucinous Medullary
Cases RR (95% FCI) Cases RR (95% FCI) Cases RR (95% FCI) Cases RR (95% FCI) Cases RR (95% FCI) Cases RR (95% FCI)
Age at menarche
o12 3764 1.02 (0.99–1.06) 790 1.22 (1.13–1.31) 229 1.04 (0.91–1.19) 213 1.13 (0.99–1.30) 59 0.85 (0.66–1.10) 20 0.84 (0.54–1.31)
12–13 7416 1.00 (0.98–1.02) 1354 1.00 (0.95–1.05) 457 1.00 (0.91–1.10) 384 1.00 (0.91–1.10) 136 1.00 (0.85–1.18) 45 1.00 (0.75–1.34)
14+ 6362 0.98 (0.95–1.00) 1129 0.95 (0.89–1.00) 354 0.87 (0.78–0.96) 319 0.94 (0.84–1.05) 128 1.04 (0.87–1.24) 50 1.27 (0.96–1.69)
Trend (per 5 years) 0.93 (0.87–0.99) 0.65 (0.56–0.76) 0.75 (0.57–0.98) 0.74 (0.55–0.99) 1.39 (0.83–2.33) 2.03 (0.83–4.96)
No. of livebirths
b
0 2334 1.00 (0.96–1.04) 383 1.00 (0.90–1.11) 131 1.00 (0.84–1.19) 121 1.00 (0.84–1.20) 56 1.00 (0.77–1.30) 10 1.00 (0.54–1.86)
1 2773 0.89 (0.86–0.92) 512 1.02 (0.94–1.11) 173 0.99 (0.85–1.15) 149 0.93 (0.79–1.09) 48 0.63 (0.47–0.83) 12 0.91 (0.51–1.59)
2 7531 0.80 (0.78–0.82) 1465 0.95 (0.90–1.00) 444 0.83 (0.76–0.91) 401 0.82 (0.74–0.91) 144 0.66 (0.56–0.78) 40 0.98 (0.72–1.35)
3+ 5256 0.71 (0.69–0.73) 963 0.81 (0.76–0.86) 314 0.81 (0.72–0.91) 271 0.71 (0.63–0.80) 82 0.43 (0.34–0.53) 54 1.65 (1.25–2.17)
Trend (per birth) 0.89 (0.88–0.91) 0.92 (0.89–0.96) 0.92 (0.87–0.98) 0.89 (0.83–0.95) 0.78 (0.70–0.87) 1.27 (1.02–1.57)
Age at first birth
c
o20 1903 1.00 (0.95–1.05) 291 1.00 (0.88–1.13) 108 1.00 (0.82–1.22) 86 1.00 (0.80–1.25) 34 1.00 (0.70–1.44) 22 1.00 (0.62–1.60)
20–24 6963 1.05 (1.03–1.07) 1282 1.24 (1.17–1.31) 453 1.27 (1.16–1.39) 373 1.24 (1.13–1.37) 121 0.94 (0.79–1.12) 50 0.73 (0.56–0.96)
25–29 4584 1.17 (1.13–1.20) 925 1.50 (1.40–1.60) 232 1.11 (0.97–1.26) 240 1.37 (1.21–1.56) 86 1.11 (0.90–1.38) 26 0.72 (0.49–1.06)
30+ 1765 1.27 (1.21–1.33) 378 1.79 (1.60–1.99) 123 1.66 (1.37–2.00) 103 1.71 (1.39–2.10) 25 0.93 (0.62–1.40) 7 0.59 (0.27–1.28)
Trend (per 5 years) 1.10 (1.07–1.12) 1.23 (1.17–1.29) 1.13 (1.03–1.23) 1.19 (1.08–1.31) 1.02 (0.86–1.22) 0.84 (0.63–1.14)
Menopausal status
d,e
Pre/peri 923 1.00 176 1.00 70 1.00 38 1.00 9 1.00 6 1.00
Post 2863 0.87 (0.79–0.97) 460 0.64 (0.49–0.83) 135 0.74 (0.50–1.12) 120 0.95 (0.59–1.54) 53 0.94 (0.34–2.58) 31 1.96 (0.66–5.81)
Age at menopause
f
o45 252 0.75 (0.66–0.85) 28 0.49 (0.34–0.71) 8 0.41 (0.21–0.83) 10 0.74 (0.40–1.38) 10 2.07 (1.11–3.88) 1 0.21 (0.03–1.49)
45–49 764 0.87 (0.81–0.94) 116 0.78 (0.64–0.94) 39 0.70 (0.50–0.98) 38 1.05 (0.76–1.46) 16 1.39 (0.85–2.28) 10 0.80 (0.42–1.55)
50–54 1451 1.00 (0.95–1.05) 253 1.00 (0.88–1.13) 78 1.00 (0.79–1.26) 60 1.00 (0.77–1.29) 22 1.00 (0.66–1.52) 18 1.00 (0.63–1.59)
55+ 310 1.22 (1.09–1.37) 50 1.04 (0.78–1.38) 9 0.71 (0.36–1.38) 12 1.24 (0.70–2.23) 5 1.14 (0.47–2.76) 2 0.61 (0.15–2.51)
Trend (per 5 years) 1.20 (1.13–1.27) 1.32 (1.14–1.52) 1.31 (0.99–1.71) 1.16 (0.88–1.53) 0.73 (0.51–1.05) 1.38 (0.79–2.40)
aAdjusted for age, geographical region, socio-economic status, smoking status, alcohol intake, physical activity, all other indices of reproductive history and HRT use.
bNot adjusted
for age at first birth.
cRestricted to parous women only.
dRestricted to never HRT users.
eConfidence intervals denote conventional rather than floated confidence intervals.
fRestricted to postmenopausal never HRT users.
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y(12%) and tubular (4%) (Table 1). Mucinous and medullary
tumours were rare, comprising 1 and 0.4%, respectively, of all
breast cancers. Mixed ductal lobular tumours comprised 3% of the
total. The median age at diagnosis (and inter-quartile range)
among women diagnosed with ductal, lobular, tubular, mixed
ductal lobular, medullary, and mucinous tumours was 59 (56–63),
60 (56–64), 58 (55–62), 60 (56–64), 59 (55–63) and 61 (58–65),
respectively. Table 1 also presents RRs for each of the six types
considered, together with the corresponding numbers of cases,
according to categories of age at menarche, parity, age at first
birth, menopausal status and age at menopause.
The RR of each of the three commonest types of breast cancer,
that is ductal, lobular and tubular tumours, decreased with
increasing age at menarche. However, the magnitude of the trend
in RR per 5-year increase in age at menarche varied considerably
by type (w2
2¼17.8; P¼0.0001; Figure 1); the largest reduction in
risk was observed for lobular (0.65, 0.56–0.76), and the smallest
for ductal cancer (0.93, 0.87–0.99). By contrast, there was little
evidence of a decrease in the risk of medullary or mucinous
cancers with increasing age at menarche (corresponding
RRs¼2.03 and 1.39, respectively), although the confidence
intervals were wide (Table 1).
There was a significant decrease in risk with increasing parity
for every subtype of breast cancer examined except medullary
cancer (Table 1). For ductal, lobular and tubular cancers, there was
no heterogeneity in the magnitude of this trend (w2
2¼3.9; P¼0.1).
The decrease in the risk of mixed ductal lobular cancers (RR per
birth¼0.89, 0.83–0.95) was similar to that for ductal (0.89, 0.88–
0.91) and lobular cancer (0.92, 0.89–0.96). There was, however, a
greater decrease in risk with increasing parity for mucinous cancer
(0.78, 0.70–0.87), than for the other types (Po0.05 for comparison
with each other subtype in turn). In contrast to the decrease in risk
with increasing parity seen for five of the tumour subtypes, there
was a significant increase in the risk of medullary cancer (1.27,
1.02–1.57) (Po¼0.005 for comparison with each other subtype in
turn; Table 1). The association between parity and breast cancer
risk was also estimated among parous women only, with
adjustment for age at first birth. The corresponding patterns of
risk across histological subtypes were broadly similar to those
calculated among all women.
Every histological subtype of breast cancer examined, except
medullary tumours, showed an increased risk with increasing age
at first birth among parous women. The RRs by age at first birth
for ductal, lobular and tubular cancer, are summarised in Figure 2.
Although the risk increased with increasing age at first birth for
each of the three commonest subtypes, there was significant
heterogeneity in the magnitude of the increase (w2
2¼15.0;
P¼0.0006). The increase in risk associated with each 5-year delay
in age at first birth was greatest for lobular cancer (RR¼1.23,
1.17–1.29).
Around 50% (601568) of women included in the main analyses
contributed to the analyses of the effect of menopause among
never-users of HRT. Among such women, the relative risk in
postmenopausal compared with premenopausal or perimenopau-
sal women was consistently lower than unity for each of the three
main types of breast cancer (Table 1), Although the reduction in
risk among postmenopausal women was less marked for ductal
cancers compared with lobular and tubular cancers, this variation
across the three main subtypes was not significant (w2
2¼5.1;
P¼0.08). Nor was there any significant difference, among
postmenopausal never-users of HRT, in the trend in risk
associated with a 5-year increase in age at menopause across the
three commonest subtypes (w2
2¼1.7; P¼0.4), although once again
the trend was least marked for ductal cancers. There were too few
cases of mucinous and medullary breast cancers among pre- and
perimenopausal women to reliably assess their relationship with
menopausal status but among postmenopausal never users of
HRT, increasing age at menopause was associated with a non-
significant trend of decreasing risk for mucinous cancer
(RR¼0.73, 0.51–1.05), and of increasing risk for medullary
cancer (RR¼1.38, 0.79–2.40).
The relationships between the various reproductive factors and
the three most common histological types of breast cancer
considered here are summarised in Figure 3. Of all the risk factors
considered, only age at menarche and age at first birth showed a
clear difference in effect across these three subtypes; both factors
being most strongly related to lobular cancers. The RR estimates
shown in Figure 3 were not materially altered when analyses were
restricted to women with valid information on all adjustment
variables.
A meta-analysis of previous studies that have assessed the effect
of age at menarche and/or age at first birth on the risk of both
ductal and lobular breast cancer, together with the findings
presented here, is shown in Figure 4. Corresponding results for
other histological subtypes were too sparse to merit meta-analysis.
Because of differences in the way in which the relationships were
assessed in each study, it was not possible to derive a comparable
estimate of relative risk from all of the previous studies. In
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Figure 1 Relative risk of specific histological types of breast cancer according to age at menarche.
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yparticular, findings from three studies (Rosen et al, 1982; Stalsberg
et al, 1989; Claus et al, 1993) could not be included in the meta-
analysis because they were based on analyses conducted only
within breast cancer cases, and findings on age at first birth from
another study (LiVoisi et al, 1982) could not be incorporated
because they were based on a different reference group. None of
the five previous studies (Li et al, 2003, 2006, 2007; Garcia-Closas
et al, 2006; Rosenberg et al, 2006) for which comparable estimates
of the effect of age at menarche were available, reported a
significant difference in the effect of age at menarche on lobular
compared with ductal cancer, although one study did find a
significantly greater effect of age at menarche on lobular compared
with ductal cancer, specifically among postmenopausal women (Li
et al, 2008). The overall relative risk in women whose age at
menarche was 14 or more, compared to less than 12, was 0.95
(0.92–0.99) for ductal cancer and 0.77 (0.71–0.83) for lobular
cancer. All eight previous studies (Ewertz and Duffy, 1988;
Wohlfahrt et al, 1999; Li et al, 2003, 2006, 2007; Garcia-Closas
et al, 2006; Rosenberg et al, 2006; Granstrom et al, 2008) included
in the meta-analysis of the effect of age at first birth showed a
greater effect on lobular than ductal cancer; however, most of these
studies had limited power and only one (Wohlfahrt et al, 1999)
reported a significant difference in the RRs for lobular and ductal
cancers according to age at first birth. Overall, the RR in women
whose age at first birth was 30 or more, as opposed to less than 20,
was 1.24 (1.20–1.29) for ductal cancer and 1.66 (1.53–1.80) for
lobular cancer. In analyses of age both at menarche and at first
birth, there was no evidence of any material variability in the
RRs of ductal and lobular cancer according to study design, or
between studies.
DISCUSSION
In this large prospective study including 27397 women with
incident invasive breast cancer, we have shown that certain aspects
of reproductive history are associated with different risks of
developing different histological types of breast cancer. In
particular, the well-known effects of age at menarche and of age
at first birth vary significantly across tumour type, with the
greatest effects seen for lobular breast cancer. Increasing parity
was associated with reductions in risk for ductal, lobular, tubular
and mucinous cancers, with a substantially greater effect for
mucinous cancers than for the other tumour types. By contrast, the
risk of medullary cancer increased with increasing parity. For most
of the reproductive factors considered, the relative risks for mixed
ductal lobular cancer were intermediate between those found for
ductal and lobular cancer.
Several studies (LiVoisi et al, 1982; Rosen et al, 1982; Ewertz and
Duffy, 1988; Stalsberg et al, 1989; Claus et al, 1993; Wohlfahrt et al,
1999; Li et al, 2003, 2006, 2007, 2008; Garcia-Closas et al, 2006;
Rosenberg et al, 2006; Granstrom et al, 2008) have published
findings on the relationship between reproductive factors and
specific histological types of breast cancer and, although the
majority found no significant differences in the effects of
reproductive risk factors according to histological type, most
lacked statistical power. Indeed only three studies (Stalsberg et al,
1989; Wohlfahrt et al, 1999; Li et al, 2008) have reported significant
differences according to histological type for at least one aspect of
reproductive history; two (Stalsberg et al, 1989; Wohlfahrt et al,
1999) found that increasing age at first birth was associated with a
significantly greater relative risk of lobular cancer and/or tubular
cancer than of ductal cancer, and one (Li et al, 2008) found a
significantly greater effect of age at menarche on lobular compared
with ductal breast cancer among postmenopausal women. A large
record-linkage study in Sweden (Granstrom et al, 2008) also
showed a greater effect of increasing age at first birth for lobular
compared with other types, and a smaller effect of low parity on
lobular compared with ductal and tubular subtypes; however, there
was limited information on potential confounders and no formal
tests of heterogeneity by histological subtype were given.
Although few individual studies have had sufficient power to
examine reliably the relationship between reproductive history and
histology, a meta-analysis of published data on the effect of age at
menarche and age at first birth on ductal and lobular cancer,
together with the present results, provides strong evidence of
material differences in their effects on these two tumour types
(Figure 4).
Only five studies have reported on the relationship between
reproductive history and the risk of relatively rare subtypes of
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Figure 2 Relative risk of specific histological types of breast cancer according to age at first birth in parous women.
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ybreast cancer (Rosen et al, 1982; Stalsberg et al, 1989; Claus et al,
1993; Wohlfahrt et al, 1999; Li et al, 2006). For mucinous tumours
(1% of all breast cancers in our cohort), two previous studies
(Stalsberg et al, 1989; Wohlfahrt et al, 1999) found that the risk in
parous compared with nulliparous women was significantly lower
than for ductal cancers. Our results are consistent with those
reports as we found a significantly greater protective effect per
birth for mucinous cancer (RR per additional birth¼0.78,
0.70–0.87) than for every other subtype examined.
For medullary tumours (0.4% of the total), our findings suggest
that several indices of reproductive history may have a qualita-
tively different relationship with risk compared with other breast
cancer subtypes. For example, medullary cancer risk increased
with increasing age at menarche and with increasing parity
but decreased with increasing age at first birth – the opposite of
what is found for the more common subtypes. The most notable
difference in the effect of parity on medullary compared with all
other subtypes examined here was statistically significant and as
far as we are aware, no previous study has reported such a
difference.
The mechanism by which reproductive factors influence the
development of breast cancer is not yet well understood, although
it is widely believed that the protective effects of a birth may be due
to the hormonal changes that occur during pregnancy and
lactation (Thomas, 1984). HRT results in a greater increase in
the incidence of lobular and tubular than of ductal cancers (Reeves
et al, 2006), and lobular breast tissue may be more responsive than
ductal to hormones involved in reproduction (Stalsberg et al,
1989). Alternatively, as lobular cancers are more likely than other
subtypes to be hormone sensitive (Li et al, 2005) the findings may
reflect a greater effect of certain reproductive factors on hormone-
sensitive breast cancers (Althuis et al, 2004). Although our findings
show clearly that age at first birth has a stronger effect on lobular
than ductal cancer, they do not suggest a corresponding difference
in the effect of parity on these two subtypes.
The Million Women Study is well placed to investigate the
relationships between reproductive history and specific histo-
logical subtypes of breast cancer as its large size affords sufficient
power for reliable comparisons. Complete follow-up for incident
cancers and information on tumour histology is coded and
routinely provided to the investigators by the NHS Central
Registers. Such information has been demonstrated to be
sufficiently valid to be used in epidemiological studies (Gathani
et al, 2005). Although age at menarche, parity and age at first birth,
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Figure 3 Summary of relationships between reproductive factors and specific histological types of breast cancer.
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those variables which may be subject to change, such as
menopausal status and HRT use, have been updated using
information obtained at resurvey for the majority of women. It
is, of course, still possible that some women may have been
misclassified, but this would not be expected to give rise to
spurious differences in relationships according to tumour
histology. Although this is the largest study to date of the effect
of reproductive factors on breast cancer histology, our findings for
the rarer tumour types, mucinous and medullary cancers, are
based on comparatively small numbers.
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Figure 4 Meta-analysis of published results on the relation between age at menarche and age at first birth, and the risk of ductal and lobular breast cancer.
Reproductive factors and breast cancer histology
GK Reeves et al
543
British Journal of Cancer (2009) 100(3), 538–544 & 2009 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
yREFERENCES
Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA (2004) Etiology
of hormone receptor-defined breast cancer: a systematic review of the
literature. Cancer Epidemiol Biomarkers Prev 13(10): 1558–1568
Claus E, Risch N, Thompson W, Carter D (1993) Relationship between
breast histopathology and family history of breast cancer. Cancer 71:
147–153
Easton DF, Peto J, Babiker AGAG (1991) Floating absolute risk: an
alternative to relative risk in survival and case-control analysis avoiding
an arbitrary reference group. Stat Med 10: 1025–1035
Ewertz M, Duffy S (1988) Risk of breast cancer in relation to reproductive
factors in Denmark. Br J Cancer 58: 99–104
Garcia-Closas M, Brinton LA, Lissowska J, Chatterjee N, Peplonska B,
Anderson WF, Szeszenia-Dabrowska N, Bardin-Mikolajczak A,
Zatonskj W, Blair A, Kalaylioglu Z, Rymkiewicz G, Mazepa-Sikora D,
Kordek R, Lukaszek S, Sherman ME (2006) Established risk factors by
clinically important tumour characteristics. Br J Cancer 95: 123–129
Gathani T, Bull D, Green J, Reeves G, Beral V, on behalf of the Million
Women Study Collaborators (2005) Breast cancer histological classifica-
tion: agreement between the Office for National Statistics and the
National Health Service Breast Screening Programme. Breast Cancer Res
7: R1090–R1096
Granstrom C, Sundquist J, Hemminki K (2008) Population attributable
risks for breast cancer in Swedish women by morphological type. Breast
Cancer Res Treat; 111: 559–568
Li C, Littman A, White E (2007) Relationship between age maximum height
is attained, age at menarche, and age at first full-term birth and breast
cancer risk. Cancer Epidemiol Biomarkers Prev 16(10): 2144–2149
Li C, Malone K, Daling J, Potter J, Bernstein L, Marchbanks P, Strom BL,
Simon MS, Press MF, Ursin G, Burkman RT, Folger SG, Norman S,
McDonald JA, Spirtas R (2008) Timing of menarche and first full-term
birth in relation to breast cancer risk. Am J Epidemiol 167: 230–239
Li C, Malone K, Porter P, Weiss N, Tang M-T, Daling J (2003) Reproductive
and anthropometric factors in relation to the risk of lobular and ductal
breast carcinoma among women 65–79 years of age. Int J Cancer 107:
647–651
Li CI, Daling J, Potter J, Bernstein L, Marchbanks PA, Liff JM, Strom BL,
Simon MS, Press MF, McDonald JA, Ursin G, Burkman RT, Deapen D,
Spirtas R (2006) Relationship between established breast cancer risk
factors and risk of seven different histologic types of invasive breast
cancer. Cancer Epidemiol Biomarkers Prev 15: 946–954
Li CI, Ubribe DJ, Daling JR (2005) Clinical characteristics of different
histological types of breast cancer. Br J Cancer 93: 1046–1052
LiVoisi V, Kelsey J, Fischer D, Holford T, Mostow E, Goldenberg I (1982)
Effect of age at first childbirth on risk of developing specific histologic
subtype of breast cancer. Cancer 49(9): 1937–1940
Million Women Study Collaborators (2003) Breast cancer and
hormone-replacement therapy in the Million Women Study. Lancet
362: 419–427
Reeves G, Beral V, Green J, Gathani T, Bull D (2006) Hormonal therapy for
the menopause and breast-cancer risk by histological type: a cohort
study and meta-analysis. Lancet Oncol 7: 910–918
Rosen P, Lesser M, Senie R, Duthie K (1982) Epidemiology of breast
carcinoma IV: age and histologic tumor type. J Surg Oncol 19: 44–47
Rosenberg L, Magnusson C, Lindstrom E, Wedren S, Hall P, Dickman P
(2006) Menopausal hormone therapy and other breast cancer risk factors
in relation to the risk of different histological subtypes of breast cancer: a
case-control study. Breast Cancer Res 8: R11
Stalsberg H, Thomas D, Noonan E (1989) Histologic types of breast
carcinoma in relation to international variation and breast cancer risk
factors. WHO Collaborative Study of Neoplasia and Steroid Contra-
ceptives. Int J Cancer 44(3): 399–409
StataCorp (2007) Statistical Software: Release 9.2. Stata: College Station, TX
The Million Women Study Collaborative Group (1999) The Million Women
Study: design and characteristics of the study population. Breast Cancer
Research 1: 73–80
Thomas DB (1984) Do hormones cause breast cancer? Cancer 53: 595–604
Townsend P, Phillimore P, Beattie A (1988) Health and Deprivation:
Inequality and the North. Croom Helm: London
Wohlfahrt J, Mouridsen H, Andersen PK, Melbye M (1999) Reproductive
risk factors for breast cancer by receptor status, histology, laterality and
location. Int J Cancer 81: 49–55
World Health Organisation (1992) International Statistical Classification of
Diseases and Related Health Problems, 10th revision World Health
Organization: Geneva
Reproductive factors and breast cancer histology
GK Reeves et al
544
British Journal of Cancer (2009) 100(3), 538–544 & 2009 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
y